A novel diphtheria toxin‐based bivalent human EGF fusion toxin for treatment of head and neck squamous cell carcinoma

Epidermal growth factor receptor (EGFR) is often overexpressed in head and neck squamous cell carcinoma (HNSCC) and represents a top candidate for targeted HNSCC therapy. However, the clinical effectiveness of current Food and Drug Administration (FDA)‐approved drugs targeting EGFR is moderate, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Zeng, Qiu, Yue, Wang, Zhaohui, Zhang, Huiping, Lu, Ling, Liu, Yanqiu, Mathes, David, Pomfret, Elizabeth A., Gao, Dexiang, Lu, Shi‐Long, Wang, Zhirui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024719/
https://www.ncbi.nlm.nih.gov/pubmed/33540470
http://dx.doi.org/10.1002/1878-0261.12919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024719/
https://www.ncbi.nlm.nih.gov/pubmed/33540470
http://dx.doi.org/10.1002/1878-0261.12919

Ejemplares similares